Valacyclovir Hydrochloride

Specifications

124832-27-5CAS Number

641-092-8EC Number

2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate;hydrochlorideIUPAC Name

C13H21ClN6O4Chemical Formula

360.8 g/molMolecular Weight

Valacyclovir hydrochloride; 124832-27-5; Valacyclovir HCl; Valaciclovir hydrochloride; 256U87 hydrochloride; BW-256U87; DTXSID2044210; NSC-759101; G447S0T1VC; Valaciclovir (as hydrochloride); 256-U-87 HYDROCHLORIDE; BW-256; DTXCID0024210; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester, monohydrochloride; RefChem:56197; L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine Hydrochloride; 2-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl L-valinate monohydrochloride; Valtrex; Valaciclovir Hcl; L-Valacyclovir Hydrochloride; 136489-37-7; Valacyclovir (hydrochloride); MFCD01861507; L-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester, hydrochloride (1:1); 256u; L-Valine, ester with 9-((2-hydroxyethoxy)methyl)guanine, monohydrochloride; (S)-2-((2-AMINO-6-OXO-1H-PURIN-9(6H)-YL)METHOXY)ETHYL 2-AMINO-3-METHYLBUTANOATE HYDROCHLORIDE; Valtrex (TN); 2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl L-valinate hydrochloride; 2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate;hydrochloride; L-Valine,2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester,monohydrochloride; C13H21ClN6O4; CHEBI:9919; CAS-124832-27-5; Valacyclovir hydrochloride [USAN]; NCGC00159520-02; UNII-G447S0T1VC; Valtrex;; 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate hydrochloride; BW 256; Valacyclovir hydrochloride [USAN:USP]; Valacicloviri hydrochloridum; SureCN1888797; SureCN5665934; SCHEMBL40830; MLS001401440; SPECTRUM1505368; VALACYCLOVIRHYDROCHLORIDE; orb1226681; orb1309816; orb3024954; CHEMBL1201110; SCHEMBL29689659; Valacyclovir hydrochloride (USP); GLXC-05274; HMS1922F20; HY-17425AR; Pharmakon1600-01505368; Valaciclovir hydrochloride (JP18); Tox21_111738; BW 256U87; EBC-11248; HY-17425A; MFCD11114398; NSC759101; AKOS008901386; AKOS015951215; Tox21_111738_1; AC-8065; CCG-100889; CCG-213402; CS-1966; FV10395; KS-1126; NC00139; NSC 759101; Valaciclovir for system suitability CRS; VALACYCLOVIR HYDROCHLORIDE [MI]; L-Valacyclovir HCl - Bio-X trade mark; L-Valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-ylmethoxy)ethyl Ester Hydrochloride; VALACICLOVIR HYDROCHLORIDE [JAN]; Valacyclovir (hydrochloride) (Standard); NCGC00178638-02; BV164502; SMR000469208; SY071104; VALACICLOVIR HYDROCHLORIDE [MART.]; VALACYCLOVIR HYDROCHLORIDE [VANDF]; Valaciclovir hydrochloride (anhydrous) CRS; VALACICLOVIR HYDROCHLORIDE [WHO-DD]; VALACICLOVIR HYDROCHLORIDE ANHYDROUS; VALACYCLOVIR HYDROCHLORIDE [USP-RS]; SW197519-2; V0111; C07184; D00398; EN300-123056; VALACYCLOVIR HYDROCHLORIDE [ORANGE BOOK]; VALACICLOVIR HYDROCHLORIDE [EP MONOGRAPH]; F861629; VALACYCLOVIR HYDROCHLORIDE [USP MONOGRAPH]; Q27888031; Z1546624231; Valacyclovir Hydrochloride Working Standard (Secondary Reference Standard); 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate; Valaciclovir for system suitability, European Pharmacopoeia (EP) Reference Standard; Valaciclovir hydrochloride (anhydrous), European Pharmacopoeia (EP) Reference Standard; Valacyclovir HCl, Pharmaceutical Secondary Standard; Certified Reference Material; Valacyclovir hydrochloride, United States Pharmacopeia (USP) Reference Standard; 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate--hydrogen chloride (1/1); 2-[(2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy]ethyl (S)-2-Amino-3-methylbutanoate Hydrochloride; 2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate;hydrochloride; 2-[(2-AMINO-6-OXO-6,9-DIHYDRO-1H-PURIN-9-YL)METHOXY]ETHYL (2S)-2-AMINO-3-METHYLBUTANOATE HYDROCHLORIDE; Valaciclovir Hydrochloride Hydrate; Valaciclovir Hydrochloride Sesquihydrate; Chlorhydrate de valaciclovir monohydraté; Chlorhydrate dihydraté de valaciclovirSynonyms